{"id":418083,"date":"2021-01-20T16:08:31","date_gmt":"2021-01-20T21:08:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=418083"},"modified":"2021-01-20T16:08:31","modified_gmt":"2021-01-20T21:08:31","slug":"dynavax-appoints-kelly-macdonald-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/","title":{"rendered":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n EMERYVILLE, Calif.<\/span>, Jan. 20, 2021<\/span> \/PRNewswire\/ —\u00a0Dynavax Technologies Corporation<\/a> (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Kelly MacDonald<\/span> has been appointed Senior Vice President and Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021<\/span>. <\/p>\n

\n

\n
\n \"Dynavax
\n <\/a>\n <\/p>\n<\/p><\/div>\n

As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach<\/span> is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter.<\/p>\n

“Michael’s contributions and unwavering commitment to Dynavax have been critical to the success of our company. We are extremely fortunate to have had his guidance over the years and now as a strategic advisor to ensure a seamless transition to his successor,” commented Ryan Spencer<\/span><\/a>, Chief Executive Officer of Dynavax. “Kelly is an accomplished financial leader with a deep understanding of corporate and commercial finance and will be an asset as we grow our business of developing vaccines to help prevent the spread of infectious diseases. On behalf of the board and the other members of the executive team, it is a pleasure to welcome Kelly to Dynavax.”<\/p>\n

“This is an exciting time to join Dynavax as it continues to build a leading vaccine company, addressing urgent global health needs,” commented Kelly MacDonald<\/span>. “I share the long-term commitment to Dynavax’ vision of collaboration, innovation and growth and look forward to leading the finance and accounting team in executing the company’s strategic and financial objectives.”<\/p>\n

Ms. MacDonald joins Dynavax from Ironwood Pharmaceuticals where she held roles of increasing responsibility. In her final role at Ironwood Ms. MacDonald served as Chief Accounting Officer and Vice President, Finance where she led the Company’s corporate accounting and finance processes, enterprise risk management, treasury and capital allocation strategy.\u00a0While at Ironwood, she also held various other managerial roles, providing finance and accounting support for the company’s strategic planning, R&D portfolio management, global business development, product launches and commercial execution. Prior to joining Ironwood, Kelly was a Manager in the Health Industries Assurance Practice at PricewaterhouseCoopers, primarily serving clients in life sciences and technology sectors.<\/p>\n

Ms. MacDonald is a Certified Public Accountant (CPA) and holds a Master of Business Administration from the Isenberg School of Management at the University of Massachusetts<\/span> and a Bachelor of Science in Accounting from Fairfield University<\/span>.<\/p>\n

\n About Dynavax
<\/b>Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company’s first commercial product, HEPLISAV-B\u00ae<\/sup> [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza. For more information, visit www.dynavax.com<\/a> and follow the company on LinkedIn<\/a>.<\/p>\n

\n Contacts:<\/b>\n <\/p>\n

\n Nicole Arndt<\/span>, Senior Manager, Investor Relations
narndt@dynavax.com<\/a>\u00a0
510-665-7264<\/p>\n

\n Derek Cole<\/span>, President
Investor Relations Advisory Solutions
derek.cole@IRadvisory.com<\/a><\/p>\n

\n

\n
\n \"(PRNewsfoto\/Dynavax
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer-301211428.html<\/a><\/p>\n

SOURCE Dynavax Technologies<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire EMERYVILLE, Calif., Jan. 20, 2021 \/PRNewswire\/ —\u00a0Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Kelly MacDonald has been appointed Senior Vice President and Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021. As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter. “Michael’s contributions and unwavering commitment to Dynavax have been critical to the success of our company. We are extremely fortunate to have had his guidance over the years and now as a strategic advisor to ensure a seamless transition to his successor,” commented Ryan … <\/p>\n

Continue reading “Dynavax Appoints Kelly MacDonald as Chief Financial Officer”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-418083","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire EMERYVILLE, Calif., Jan. 20, 2021 \/PRNewswire\/ —\u00a0Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Kelly MacDonald has been appointed Senior Vice President and Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021. As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter. “Michael’s contributions and unwavering commitment to Dynavax have been critical to the success of our company. We are extremely fortunate to have had his guidance over the years and now as a strategic advisor to ensure a seamless transition to his successor,” commented Ryan … Continue reading "Dynavax Appoints Kelly MacDonald as Chief Financial Officer"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T21:08:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dynavax Appoints Kelly MacDonald as Chief Financial Officer\",\"datePublished\":\"2021-01-20T21:08:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/\"},\"wordCount\":516,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1423154\\\/MacDonald_HS8.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/\",\"name\":\"Dynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1423154\\\/MacDonald_HS8.jpg\",\"datePublished\":\"2021-01-20T21:08:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1423154\\\/MacDonald_HS8.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1423154\\\/MacDonald_HS8.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dynavax Appoints Kelly MacDonald as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk","og_description":"PR Newswire EMERYVILLE, Calif., Jan. 20, 2021 \/PRNewswire\/ —\u00a0Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Kelly MacDonald has been appointed Senior Vice President and Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021. As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter. “Michael’s contributions and unwavering commitment to Dynavax have been critical to the success of our company. We are extremely fortunate to have had his guidance over the years and now as a strategic advisor to ensure a seamless transition to his successor,” commented Ryan … Continue reading \"Dynavax Appoints Kelly MacDonald as Chief Financial Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T21:08:31+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer","datePublished":"2021-01-20T21:08:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/"},"wordCount":516,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/","name":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg","datePublished":"2021-01-20T21:08:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1423154\/MacDonald_HS8.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-appoints-kelly-macdonald-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dynavax Appoints Kelly MacDonald as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=418083"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418083\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=418083"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=418083"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=418083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}